Alexion Pharm Inc
(ALXN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 122,600 | -208,300 | 249,100 | 443,300 | 413,300 |
| Depreciation Amortization | 306,900 | 202,000 | 101,500 | 496,700 | 311,600 |
| Income taxes - deferred | 79,100 | 111,500 | 88,800 | -45,900 | -57,300 |
| Accounts receivable | -197,400 | -137,000 | -42,700 | -55,200 | -34,600 |
| Accounts payable and accrued liabilities | N/A | N/A | -73,700 | N/A | N/A |
| Other Working Capital | -423,100 | -327,400 | -145,200 | -170,500 | -115,600 |
| Other Operating Activity | 454,500 | 314,700 | 121,500 | 447,200 | 340,100 |
| Operating Cash Flow | $342,600 | $-44,500 | $299,300 | $1,115,600 | $857,500 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 585,300 | 440,400 | -190,200 | -561,100 | -650,000 |
| PPE Investments | -170,600 | -129,400 | -66,600 | -357,300 | -268,800 |
| Other Investing Activity | 3,600 | 2,600 | 2,100 | 100 | 100 |
| Investing Cash Flow | $418,300 | $313,600 | $-254,700 | $-918,300 | $-918,700 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 250,000 | 250,000 | N/A | N/A | N/A |
| Debt Repayment | -293,800 | -293,800 | -43,800 | -175,000 | -131,300 |
| Common Stock Issued | 41,400 | 24,600 | 9,400 | N/A | 76,000 |
| Common Stock Repurchased | -85,000 | -85,000 | -85,000 | -463,600 | -298,500 |
| Other Financing Activity | -18,100 | -12,300 | -4,100 | 42,000 | -17,400 |
| Financing Cash Flow | $-105,500 | $-116,500 | $-123,500 | $-596,600 | $-371,200 |
| Exchange Rate Effect | -10,600 | -6,100 | 6,300 | 17,700 | 16,500 |
| Beginning Cash Position | 586,300 | 586,300 | 586,300 | 966,000 | 966,000 |
| End Cash Position | 1,231,100 | 732,800 | 513,700 | 584,400 | 550,100 |
| Net Cash Flow | $644,800 | $146,500 | $-72,600 | $-381,600 | $-415,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | 342,600 | -44,500 | 299,300 | 1,115,600 | 857,500 |
| Capital Expenditure | -170,600 | -129,400 | -66,600 | -357,300 | -268,800 |
| Free Cash Flow | 172,000 | -173,900 | 232,700 | 758,300 | 588,700 |